474 related articles for article (PubMed ID: 10199797)
1. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.
Huber-Buchholz MM; Carey DG; Norman RJ
J Clin Endocrinol Metab; 1999 Apr; 84(4):1470-4. PubMed ID: 10199797
[TBL] [Abstract][Full Text] [Related]
2. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
3. Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome.
van Dam EW; Roelfsema F; Veldhuis JD; Hogendoorn S; Westenberg J; Helmerhorst FM; Frölich M; Krans HM; Meinders AE; Pijl H
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E615-20. PubMed ID: 14678951
[TBL] [Abstract][Full Text] [Related]
4. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
6. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study.
Palomba S; Giallauria F; Falbo A; Russo T; Oppedisano R; Tolino A; Colao A; Vigorito C; Zullo F; Orio F
Hum Reprod; 2008 Mar; 23(3):642-50. PubMed ID: 18158291
[TBL] [Abstract][Full Text] [Related]
7. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
[TBL] [Abstract][Full Text] [Related]
8. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
9. Resumption of ovulation in anovulatory women with PCOS and obesity is associated with reduction of 11β-hydroxyandrostenedione concentrations.
Wang Z; Van Faassen M; Groen H; Cantineau AEP; Van Oers A; Van der Veen A; Hawley JM; Keevil BG; Kema IP; Hoek A
Hum Reprod; 2024 May; 39(5):1078-1088. PubMed ID: 38503490
[TBL] [Abstract][Full Text] [Related]
10. In women with polycystic ovary syndrome and obesity, loss of intra-abdominal fat is associated with resumption of ovulation.
Kuchenbecker WK; Groen H; van Asselt SJ; Bolster JH; Zwerver J; Slart RH; Vd Jagt EJ; Muller Kobold AC; Wolffenbuttel BH; Land JA; Hoek A
Hum Reprod; 2011 Sep; 26(9):2505-12. PubMed ID: 21771766
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
Arroyo A; Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
13. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
Jiskoot G; Benneheij SH; Beerthuizen A; de Niet JE; de Klerk C; Timman R; Busschbach JJ; Laven JS
Reprod Health; 2017 Mar; 14(1):34. PubMed ID: 28264692
[TBL] [Abstract][Full Text] [Related]
14. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
15. The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.
Moran LJ; Noakes M; Clifton PM; Norman RJ
J Clin Endocrinol Metab; 2007 Oct; 92(10):3796-802. PubMed ID: 17652213
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].
Liu ZA; Xue YM; Chen LX; Cai Q; Chen H; Zhang J; Cui QH; Ge J; Yuan T
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):586-90. PubMed ID: 15498183
[TBL] [Abstract][Full Text] [Related]
17. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
18. Heart rate recovery improves after weight loss in overweight and obese women with polycystic ovary syndrome.
Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
Fertil Steril; 2010 Mar; 93(4):1173-8. PubMed ID: 19147136
[TBL] [Abstract][Full Text] [Related]
19. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
[TBL] [Abstract][Full Text] [Related]
20. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
